Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Rituximab in the Treatment of Graves' Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE2
Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- NA
Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1
- Status
- COMPLETED
- Phase
- PHASE3
Primary Rituximab and Maintenance
- Status
- COMPLETED
- Phase
- PHASE3
R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2